STOCK TITAN
  1. Home
  2. Sec-filings
  3. PROK
  4. [EFFECT] ProKidney Corp. SEC Filing

[EFFECT] ProKidney Corp. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 7, 2025
Accession Number: 0001140361-25-024903
Submission Type: POS AM
CIK: 0001850270
Company Name: PROKIDNEY CORP.
File Number: 333-275701

Source: View Original Filing on SEC EDGAR

ProKidney

NASDAQ:PROK

View PROK Stock Overview →

PROK Rankings

#4045 Ranked by Market Cap
N/A Ranked by Dividends

PROK Latest News

Mar 18, 2026
ProKidney Reports Full Year 2025 Financial Results and Business Highlights
Jan 6, 2026
ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference
Nov 10, 2025
ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
Nov 6, 2025
ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025
Oct 29, 2025
ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference

PROK Latest SEC Filings

Mar 18, 2026
[10-K] PROKIDNEY CORP. Files Annual Report
Mar 18, 2026
[8-K] PROKIDNEY CORP. Reports Material Event
Mar 3, 2026
[Form 4] PROKIDNEY CORP. Insider Trading Activity
Mar 3, 2026
[Form 4] PROKIDNEY CORP. Insider Trading Activity
Mar 3, 2026
[Form 4] PROKIDNEY CORP. Insider Trading Activity

PROK Stock Data

304.32M
105.62M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
WINSTON-SALEM